InMed Pharmaceuticals Inc. (OTCMKTS:IMLFF – Get Free Report)’s share price passed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $0.26 and traded as low as $0.25. InMed Pharmaceuticals shares last traded at $0.26, with a volume of 214,726 shares.
InMed Pharmaceuticals Price Performance
The company’s fifty day moving average price is $0.26 and its 200 day moving average price is $0.29.
About InMed Pharmaceuticals
InMed Pharmaceuticals Inc, a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of orofacial pain.
Featured Articles
- Five stocks we like better than InMed Pharmaceuticals
- How to Capture the Benefits of Dividend Increases
- How Much Can You Make in Stocks in One Month?
- Investing in Commodities: What Are They? How to Invest in Them
- This Is the Top Large-Cap Stock Insiders Are Buying
- Stock Dividend Cuts Happen Are You Ready?
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for InMed Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMed Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
